Further clinical studies have shown that changes in the levels of the autophagy marker Beclin-1 are strongly associated with the response to medication for depression and that Beclin-1 may serve as an independent predictor of the efficacy of medication for depression [96]. This evidence concerns the gene BECN1 and depressive disorder.